FDA moves toward easing restrictions on certain peptides BioPharma Dive Best Peptide Tracking Apps 2026 Protocol vs PepTracker, Pep AI, PeptIQ, Peptify Watergram Water Balance Calculator (circular) Taylor Technologies In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn